Agenda: Seattle’s Life Science Disruptors

5.2.2016  AGENDA
12:30  1:30 Registration & Networking
1:30  1:40 Welcome
Nicole Robinson, Fred Hutchinson Cancer Research Center
Jim Edwards, Xconomy
1:40  2:00 Update From The Immuno-Oncology Trenches
Rob Hershberg, Celgene
2:00  2:15 CD19 CAR-T Cell Immunotherapy: A Case Study
Cameron Turtle
, Fred Hutchinson Cancer Research Center
2:15  2:30 Immunotherapy Beyond Cancer
Andrew Scharenberg
, Seattle Children’s Research Institute
2:30  2:55 Wellness and Prevention, 21st Century Priorities
Clayton Lewis, Arivale
Molly Moore, Cambia Health Solutions
Alex Lash, Xconomy (moderator)
2:55  3:25 From AIDS To Zika, Combating Global Health Crises
Jennifer Dent, BIO Ventures for Global Health
Larry Corey, HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center
Jim Thomas, Just Biotherapeutics
Rhea Coler, Infectious Disease Research Institute
3:25  4:00 Networking Break
4:00 – 4:25 Sharing Data For Better Health
Stephen Friend, Sage Bionetworks
Matthew Trunnell, Fred Hutchinson Cancer Research Center
Panel Moderated by:
Austin Walsh, IBM
4:25 – 4:40 The State Of Seattle Startups
Thong Le
, Accelerator
In conversation with Alex Lash, Xconomy
4:40 – 5:00 M3 Biotechnology: A Founder-Investor Story
Leen Kawas
, M3 Biotechnology
John Fluke, Fluke Capital Management
Alex Lash, Xconomy (moderator)

5:00 – 5:30 Proteins Like You’ve Never Seen
David Baker, University of Washington
Aaron Chevalier, Virvio
Lucas Nivon, Cyrus Biotechnology
Ingrid Swanson Pultz, PVP Biologics
Alex Lash, Xconomy (moderator)
5:30 – 6:30 Networking Reception